Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: a comparative study with HbA1c and glycated albumin

Background 1,5-Anhydroglucitol (1,5-AG) is a new blood glucose control marker reflecting temporary glucose elevations. However, 1,5-AG is of limited value in patients with advanced renal insufficiency. The aim of the present study was to assess the correlation between 1,5-AG levels and renal functio...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasslacher, Christoph (Author) , Kulozik, Felix (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: Journal of diabetes
Year: 2015, Volume: 8, Issue: 5, Pages: 712-719
ISSN:1753-0407
DOI:10.1111/1753-0407.12354
Online Access:Verlag, Volltext: https://doi.org/10.1111/1753-0407.12354
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/1753-0407.12354
Get full text
Author Notes:Christoph Hasslacher and Felix Kulozik
Description
Summary:Background 1,5-Anhydroglucitol (1,5-AG) is a new blood glucose control marker reflecting temporary glucose elevations. However, 1,5-AG is of limited value in patients with advanced renal insufficiency. The aim of the present study was to assess the correlation between 1,5-AG levels and renal function in patients with earlier stages of nephropathy compared with another two markers of diabetes control, namely HbA1c and glycated albumin (GA). Methods The following parameters were measured in 377 patients with type 2 diabetes: HbA1c, serum concentrations of 1,5-AG, GA and creatinine, hemoglobin, urinary albumin/creatinine ratio, and urinary excretion of α1-microglobulin (A1M). Estimated glomerular filtration rate (eGFR) was calculated according to the Cockgroft-Gault formula. Results There was a negative correlation between 1,5-AG and renal function (r = −0.18; P < 0.001). Concentrations of 1,5-AG were, on average, 27.2% lower in patients with glomerular hyperfiltration (eGFR >120 mL/min) compared with patients with moderate renal impairment (eGFR 30-59 mL/min; P = 0.016). In contrast, HbA1c, GA levels and urinary A1M excretion did not differ between the two patient groups. The mean age of patients with eGFR 30-59 mL/min was substantially higher than that of patients with glomerular hyperfiltration (P < 0.001). Thus, an age-related change in the renal glucose threshold could be the reason for the observed correlation between 1,5-AG and renal function. Conclusions In clinical practice, age and renal function must be taken into consideration when interpreting 1,5-AG levels, even in the absence of advanced renal impairment.
Item Description:First published: 28 November 2015
Gesehen am 07.08.2019
Physical Description:Online Resource
ISSN:1753-0407
DOI:10.1111/1753-0407.12354